Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

U.K. launch for Posicor

Jan. 27, 1998

ACAT-inhibitory anilides from Kowa are particularly useful for atherosclerosis

Jan. 27, 1998

Takeda discloses compounds that upregulate LDL receptors

Jan. 27, 1998

Adenosine metabolism inhibitor research at Cypros supported by grant

Jan. 26, 1998

Atherosclerosis program at Genome Therapeutics expanded

Jan. 26, 1998

Two NDAs up for review this week by Cardiovascular and Renal Drugs Advisory Committee

Jan. 26, 1998

T Cell Sciences awarded SBIR grant for atherosclerosis vaccine

Jan. 23, 1998

SmithKline Beecham presents new azetidinones for atherosclerosis

Jan. 23, 1998

Japan Energy describes inhibitors of SMC proliferation

Jan. 22, 1998

Novel coronary artery disease gene therapy scheduled to enter clinical trials

Jan. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...